159 related articles for article (PubMed ID: 34584583)
41. The importance of calprotectin for differentiating organic inflammatory disease and avoiding unnecessary procedures in paediatrics.
García Romero R; López Ubeda M; Cardiel Valiente L; Ros Arnal I
Med Clin (Barc); 2018 Sep; 151(6):231-235. PubMed ID: 29292106
[TBL] [Abstract][Full Text] [Related]
42. Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases.
Roszak D; Gałęcka M; Cichy W; Szachta P
Adv Med Sci; 2015 Sep; 60(2):246-52. PubMed ID: 25989184
[TBL] [Abstract][Full Text] [Related]
43. B cell-activating factor (BAFF) in children with inflammatory bowel disease.
Fodor I; Serban O; Serban DE; Farcau D; Man SC; Dumitrascu DL
Pediatr Res; 2021 May; 89(7):1798-1803. PubMed ID: 32937648
[TBL] [Abstract][Full Text] [Related]
44. Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.
Lozoya Angulo ME; de Las Heras Gómez I; Martinez Villanueva M; Noguera Velasco JA; Avilés Plaza F
Gastroenterol Hepatol; 2017 Mar; 40(3):125-131. PubMed ID: 27260632
[TBL] [Abstract][Full Text] [Related]
45. Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years.
Kennedy NA; Clark A; Walkden A; Chang JC; Fascí-Spurio F; Muscat M; Gordon BW; Kingstone K; Satsangi J; Arnott ID; Lees CW
J Crohns Colitis; 2015 Jan; 9(1):41-9. PubMed ID: 25135754
[TBL] [Abstract][Full Text] [Related]
46. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms.
Mowat C; Digby J; Strachan JA; Wilson R; Carey FA; Fraser CG; Steele RJ
Gut; 2016 Sep; 65(9):1463-9. PubMed ID: 26294695
[TBL] [Abstract][Full Text] [Related]
47. Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease.
Jang HW; Kim HS; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
Intest Res; 2016 Oct; 14(4):305-313. PubMed ID: 27799881
[TBL] [Abstract][Full Text] [Related]
48. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
49. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
Yang Z; Clark N; Park KT
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
[TBL] [Abstract][Full Text] [Related]
50. Correlation between faecal calprotectin and magnetic resonance imaging (MRI) in the evaluation of inflammatory pattern in Crohn's disease.
Zippi M; Al Ansari N; Siliquini F; Severi C; Kagarmanova A; Maffia C; Parlanti S; Garbarino V; Maccioni F
Clin Ter; 2010; 161(2):e53-6. PubMed ID: 20499020
[TBL] [Abstract][Full Text] [Related]
51. Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectin.
Karling P; Lundgren D; Eklöf V; Palmqvist R; Hultdin J
Scand J Clin Lab Invest; 2019 Sep; 79(5):341-346. PubMed ID: 31164011
[TBL] [Abstract][Full Text] [Related]
52. Faecal calprotectin in children with chronic gastrointestinal symptoms.
Bremner A; Roked S; Robinson R; Phillips I; Beattie M
Acta Paediatr; 2005 Dec; 94(12):1855-8. PubMed ID: 16421055
[TBL] [Abstract][Full Text] [Related]
53. Limitations of the determination of faecal calprotectin in patients with ulcerative colitis and inflammatory polyps.
Bermejo F; Algaba A; Bonillo D; Jiménez L; Guardiola-Arévalo A; Pacheco M; Castaño Á; Guerra I
Gastroenterol Hepatol; 2020 Feb; 43(2):73-78. PubMed ID: 31648810
[TBL] [Abstract][Full Text] [Related]
54. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
Kolho KL; Raivio T; Lindahl H; Savilahti E
Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
[TBL] [Abstract][Full Text] [Related]
55. Faecal calprotectin as a diagnostic marker of inflammatory bowel disease in patients with gastrointestinal symptoms: meta-analysis.
Petryszyn P; Staniak A; Wolosianska A; Ekk-Cierniakowski P
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1306-1312. PubMed ID: 31464777
[TBL] [Abstract][Full Text] [Related]
56. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
Johnson MW; Maestranzi S; Duffy AM; Dewar DH; Forbes A; Bjarnason I; Sherwood RA; Ciclitira P; Nicholls JR
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):174-9. PubMed ID: 18301296
[TBL] [Abstract][Full Text] [Related]
57. Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation.
Fu Y; Wang L; Xie C; Zou K; Tu L; Yan W; Hou X
Sci Rep; 2017 Jun; 7(1):2669. PubMed ID: 28572616
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of point-of-care test calprotectin and lactoferrin for inflammatory bowel disease among children with chronic gastrointestinal symptoms.
Holtman GA; Lisman-van Leeuwen Y; van Rheenen PF; Kollen BJ; Escher JC; Kindermann A; de Rijke YB; Berger MY
Fam Pract; 2017 Aug; 34(4):400-406. PubMed ID: 27535331
[TBL] [Abstract][Full Text] [Related]
59. A simple method for assessing intestinal inflammation in Crohn's disease.
Tibble J; Teahon K; Thjodleifsson B; Roseth A; Sigthorsson G; Bridger S; Foster R; Sherwood R; Fagerhol M; Bjarnason I
Gut; 2000 Oct; 47(4):506-13. PubMed ID: 10986210
[TBL] [Abstract][Full Text] [Related]
60. Mucosal and faecal neutrophil gelatinase-associated lipocalin as potential biomarkers for collagenous colitis.
Bakke I; Walaas GA; Bruland T; Røyset ES; van Beelen Granlund A; Escudero-Hernández C; Thorsvik S; Münch A; Sandvik AK; Østvik AE
J Gastroenterol; 2021 Oct; 56(10):914-927. PubMed ID: 34414506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
